Donor Lymphocyte Infusion for the Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
- 1 January 1998
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 29 (3-4), 301-313
- https://doi.org/10.3109/10428199809068567
Abstract
The results of donor lymphocyte infusion (DLI) for treatment of relapse after bone marrow transplantation (BMT) are reviewed. Durable complete remission can be achieved at the molecular level for a majority (more than 70%) of patients with CML, when treated at early relapse. Results are less favourable for acute leukemias, although useful responses have been reported. Data are scarce though promising for myelodysplastic syndromes and multiple myeloma. Major treatment-associated toxicities are GVHD and bone marrow aplasia. The latter complication can be predicted by evaluating the level of residual donor-derived hematopoiesis. Modification of infused cells (CD8 negative selection or transduction with a suicide gene), addition of peripheral blood stem cells, and early implementation of escalating doses may counteract the complications and increase the response rate. Response rate is variably influenced by the presence of chronic GVHD after initial BMT, T-cell depleted BMT, underlying disease and stage at relapse, and the level of mixed chimerism. DLI is a direct demonstration of the graft-versus-leukemia effect (GVL). Because GVL after BMT is sometimes the predominant cause of cure, it may be advisable in such situations to redirect the conditioning regimens for BMT towards engraftment and less immediate cytotoxicity.Keywords
This publication has 72 references indexed in Scilit:
- HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeBritish Journal of Haematology, 1992
- DURABLE COMPLETE REMISSION OF ACUTE NONLYMPHOCYTIC LEUKEMIA ASSOCIATED WITH DISCONTINUATION OF IMMUNOSUPPRESSION FOLLOWING RELAPSE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988
- Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effectBritish Journal of Haematology, 1988
- Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow graftsBlood, 1985
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- REMISSION OF RELAPSED LEUKÆMIA DURING A GRAFT-VERSUS-HOST REACTION A "GRAFT-VERSUS-LEUKÆMIA REACTION" IN MAN?The Lancet, 1978
- ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMSAnnals of the New York Academy of Sciences, 1976
- Treatment of Murine Leukaemia with X‐Rays and Homologous Bone Marrow: IIBritish Journal of Haematology, 1957